August 18, 2017: Thomas Wynn, who after 26 years as a senior investigator at the National Institutes of Health (NIH) is leaving to lead Pfizer’s inflammation and immunology unit.
August 18, 2017: Greg Mayes founded Engage Therapeutics to find a better preventive approach for his son’s epilepsy. To keep the company afloat, Mayes needs to raise $21M—by the end of August.
August 18, 2017: Pfizer’s newly approved leukemia drug Besponsa (inotuzumab ozogamicin) will come with a black box warning over concerns of liver toxicity.
August 18, 2017: Biotech stocks can be a great investment, at least for people with strong stomachs. Here's a look at the three best healthcare stocks.